Journal of Mid-life Health · 2016 · 49 citations · 14 references
MedicineEndocrinologyGynecologyReproductive EndocrinologyReproductive EpidemiologyWomen's HealthDiabetes MellitusInsulin ResistanceMenopause ManagementMetabolic DiseaseMetabolic EndocrinologyMetabolic SyndromeCardiovascular Disease PrevalenceCardiovascular Risk After MenopauseInsulin Resistance SyndromeLipid Profile ChangesMenopausal StatusMetabolic Syndrome EpidemiologyPrevalence Estimation
BACKGROUND: The metabolic syndrome (MS) (syndrome X, insulin resistance syndrome) is a constellation of metabolic abnormalities and a complex predisease state that predicts future development of type 2 diabetes mellitus and cardiovascular disease. Menopausal transition and postmenopausal state are considered as a vulnerable period for developing MS, and this increased risk has been attributed to decreasing estrogen levels with an increasing risk of insulin resistance following menopause. AIMS AND OBJECTIVES: This study aimed to determine the prevalence of MS and its components in pre- and post-menopausal women from North India. METHODOLOGY: This is a cross-sectional study of 350 women in the age group of 45-55 years attending gynecology clinic in a tertiary center of North India. Details of sociodemographic data, menopausal history, reproductive, and medical profile were obtained. Then, waist circumference, body mass index (BMI), and blood pressure were recorded. A venous blood sample was collected for fasting blood glucose, triglycerides, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. MS was defined according to the modified National Cholesterol Education Program Adult Treatment Panel III criteria. RESULTS: The mean age was 49.09 ± 2.2 years in premenopausal and 49.54 ± 2.8 years in postmenopausal women. The prevalence of MS in the study group was 62.6%. Occurrence of MS was higher in older and obese women. Abnormal waist circumference was the most prevalent component (87%) of MS and in terms of odd ratio, correlation was highest for BMI followed by total cholesterol and waist-hip ratio. CONCLUSION: We should target obesity and deranged lipid profile by bringing out changes in lifestyle and dietary habits to decrease the higher prevalence of MS and the risk of cardiovascular diseases.
14
Prevalence of the Metabolic Syndrome Among US Adults
Earl S. Ford, Wayne H. Giles, William H. Dietz · JAMA · 2002 · 6.7K citations
Megan Dalton, Adrian J. Cameron, Paul Zimmet et al. · Journal of Internal Medicine · 2003 · 679 citations · Full text
Prevalence of Metabolic Syndrome in Urban India
Apurva Sawant, Ranjit Mankeshwar, Swarup A.V. Shah et al. · Cholesterol · 2011 · 138 citations · Full text
Medicine, Cardiology, Endocrinology +16